Physician profile
Anna Collard
NPI 1891675013
$472.19
in general payments reported to CMS, 2019-2025
9 companies · $472 in 2025
The $472 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $472.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $472.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $472.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $230.00 | 2025 | Tremfya, Simponi Aria |
| Ucb, INC. | $56.71 | 2025 | Bimzelx |
| Sandoz INC. | $49.30 | 2025 | Jubbonti |
| Organon LLC | $39.44 | 2025 | Hadlima |
| Genentech USA, INC. | $25.78 | 2025 | Actemra |
| Astrazeneca Pharmaceuticals Lp | $20.64 | 2025 | Saphnelo |
| Almatica Pharma LLC | $18.04 | 2025 | Teriparatide |
| Sobi, INC | $17.14 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.14 | 2025 | Ofev |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Collard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.